TechCrunch describes how Nephrogen used credibility signals to pitch investors
TechCrunch says its Build Mode discussion explores explaining complex biotech to generalist investors—and why Q&A should be treated as a second pitch.
TLDR
TechCrunch says early-stage deep tech startups can seem risky to investors and highlights Nephrogen’s Startup Battlefield pitch as an example of using credibility signals to overcome that perception. Its Build Mode episode examines what worked in the pitch and what could improve. The discussion covers simplifying technical ideas without oversimplifying, how deck design affected the founder’s confidence onstage, and using AI to prepare for difficult investor questions.
Combined views
41K
1 Source, first seen ago